Aims & Scope

Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease.

The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics.

Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.

ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics.

ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research.

ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.

ARS coverage includes: -ROS/RNS as messengers -Gaseous signal transducers -Hypoxia and tissue oxygenation -microRNA -Prokaryotic systems -Lessons from plant biology

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 6.1
2024 5.90

Journal Rank

Year Value
2024 1511

Journal Citation Indicator

Year Value
2024 3112

SJR (SCImago Journal Rank)

Year Value
2024 1.951

Quartile

Year Value
2024 Q1

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.


Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.


Quick Facts

Current Factor
6.1
First Published: 2025

SJR (SCImago Journal Rank)

SJR
1.951
First Published: 2024

Quartile

Current Quartile
Q1
First Published: 2024

Similar Journals

Top Journals in Related Fields